Mixed open over earnings

The markets opened mixed with the Dow losing 25 points to 20,498 while Nasdaq gained 33 points to 5,882 as investors monitored earnings news.


On the upside


Soligenix (Nasdaq: SNGS) will present results from its ricin toxin vaccine development program at the 20th Annual Conference on Vaccine Research on April 25.


Ultragenyx Pharmaceutical (Nasdaq: RARE) reported positive results from a Phase 3 study of burosumab to treat X-linked hypophosphatemia.


Lam Research (Nasdaq: LRCX) reported sharply higher third quarter earnings that beat analyst expectations.


On the downside


Sunshine Heart (Nasdaq: SSH) priced its public offering of common stocks and warrants at the discounted price of $1.00 per unit.


International Business Machines (NYSE: IBM) disappointed with lower fourth quarter revenue that fell short of expectations.

Investors locked in profits on Interpace Diagnostics Group (Nasdaq: IDXG).


In the broad market, advancing issues outpaced decliners by a margin of 5 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 index gained 6 points to 2,348. Bitcoin held steady at $1206.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.